New Asthma Drug Generates Excitement For Patients — And Its Maker – Forbes

New Asthma Drug Generates Excitement For Patients — And Its Maker
Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough and give yet another boost to Regeneron Pharmaceuticals, the company developing it, which has seen its shares rise 376% in the past two years,
Regeneron, Sanofi asthma drug seen as potential game changerReuters
Monoclonal antibody appears effective and safe in asthma Phase IIa trialScience Codex
Sanofi, Regeneron Report Publication Of Phase 2a Results Of Dupilumab In RTT News
MarketWatch (press release)
all 5 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.